SEC Comment Letter for vTv Therapeutics Inc. (VTVT) (CIK 0001641489) (VTVT) — Jan 17, 2018

vTv Therapeutics Inc. (VTVT) (CIK 0001641489)
Date: Jan. 17, 2018 · CIK: 0001641489 · Accession: 0000000000-18-001626

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

January 17, 2018

Author

Rudy C. Howard

Form

UPLOAD

Company

vTv Therapeutics Inc. (VTVT) (CIK 0001641489)

Letter

January 17, 2018 Rudy C. Howard Chief Financial Officer vTv Therapeutics, Inc. 4170 Mendenhall Oaks Parkway High Point, North Carolina 27265 vTv Therapeutics, Inc. Form 10-K for the Fiscal Year Ended December 31, 2016 Filed February 24, 2017 and Amended January 16, 2018 File No. 001-37524Re: Dear Mr. Howard: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence by the staff. Division of Corporation Finance Office of Healthcare & Insurance

Show Raw Text

January 17, 2018
Rudy C. Howard
Chief Financial Officer
vTv Therapeutics, Inc.
4170 Mendenhall Oaks Parkway
High Point, North Carolina 27265
vTv Therapeutics, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2016
Filed February 24, 2017 and Amended January 16, 2018
File No. 001-37524Re:
Dear Mr. Howard:
            We have completed our review of your filings.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence by the staff.
Division of Corporation Finance
Office of Healthcare & Insurance

SecProbe.io